The medical device market in China is undergoing rapid expansion, exhibiting distinct characteristics and trends. Key aspects of its development include:
Stable Growth: The market has demonstrated consistent expansion, growing from approximately RMB 296.6 billion in 2012 to RMB 1.27 trillion in 2023, reflecting a significant compound annual growth rate (CAGR). Growth is projected to continue at around 10% annually in the coming years.
Key Drivers: This expansion is primarily fueled by rising domestic healthcare demand, continuous technological advancements, and strong government policy support.
Emerging Innovative Products: By May 2024, China had approved 271 innovative medical devices, an increase over the previous year. These novel products are expected to further propel market growth.
Adoption of Emerging Technologies: Rapid developments in wearable devices, medical robotics, and other new technologies are enhancing product intelligence, personalization, and precision, thereby improving healthcare service efficiency and quality.
Growing Enterprise Base: The number of medical device manufacturers has surged significantly, intensifying market competition. However, the competitive landscape is gradually maturing through industry consolidation and technological innovation.
Domestic Substitution Gains Momentum: Driven by robust domestic demand and technological breakthroughs, locally manufactured medical devices are increasingly replacing imported products and capturing larger market shares.
Resilient Export Performance: Despite international uncertainties, China's medical device exports have maintained steady growth, with annual volumes expected to remain robust.
Enhanced Global Competitiveness: Through technological innovation and brand building, Chinese enterprises are strengthening their position in the global market and actively exploring new international opportunities.
Favorable Policy Environment: The Chinese government has implemented a series of supportive policies, including tax incentives and financial measures, to foster industry growth.
Strategic Direction: Guided by policy, the industry is trending towards innovation, digitalization, localization, green development, and internationalization, supporting its high-quality transformation.
Impact of Volume-Based Procurement (VBP): Centralized procurement policies have exerted downward pressure on prices for some high-value devices, compelling companies to accelerate innovation and seek new growth avenues.
Strengthened Regulation: Regulatory bodies, such as the National Medical Products Administration (NMPA) and the National Health Commission (NHC), have issued requirements for the temporary import and use of urgently needed clinical devices to ensure patient safety and market order.
The Chinese medical device market benefits significantly from the vast potential demand generated by its large population base, coupled with continuous technological progress and a supportive policy environment. Looking ahead, the integration of advanced international technologies with domestic innovation capabilities is expected to sustain high growth rates and elevate the market's global significance.
Contact Person: Ms. Sunny liu
Tel: +86 188 24657545
Fax: 86-755-83254980